Buscar
Mostrando ítems 11-20 de 21
A single amino acid substitution in isozyme GST mu in Triclabendazole resistant Fasciola hepatica (Sligo strain) can substantially influence the manifestation of anthelmintic resistance.
(Academic Press Inc., 2015)
The helminth parasite Fasciola hepatica causes fascioliasis in human and domestic ruminants. Economic losses due to this infection are estimated in U$S 2000-3000 million yearly. The most common method of control is the use ...
Molecular characterization and phylogenetic analysis of Fasciola hepatica from Peru.
(Elsevier Ireland Ltd., 2016)
The causative agent of fasciolosis in South America is thought to be Fasciola hepatica. In this study, Fasciola flukes from Peru were analyzed to investigate their genetic structure and phylogenetic relationships with those ...
Independent origins and non-parallel selection signatures of triclabendazole resistance in Fasciola hepatica.
(Nature Research., 2025)
Triclabendazole (TCBZ) is the primary treatment for fascioliasis, a global foodborne zoonosis caused by Fasciola hepatica. Widespread resistance to TCBZ (TCBZ-R) in livestock and a rapid rise in resistant human infections ...
Western blot technique standardization of the diagnosis of human fasciolosis using Fasciola hepatica excreted-secreted antigens.
(Instituto Nacional de Salud., 2011)
Objectives: To evaluate the performance of the enzyme-linked immunoelectrotransfer blot assay (EITB, Western blot) using excretory/secretory antigens from adult forms of Fasciola hepatica (Fh E/S Ag) for the diagnosis of ...
Distinct gut microbiome features characterize Fasciola hepatica infection and predict triclabendazole treatment outcomes in Peruvian patients.
(Frontiers Media SA., 2025)
Background Fasciola hepatica, a globally distributed helminth, causes fasciolosis, a disease with significant health and economic impacts. Variability in triclabendazole (TCBZ) efficacy and emerging resistance are remaining ...
Fasciola hepatica phenotypic characterization in Andean human endemic areas: Valley versus altiplanic patterns analysed in liver flukes from sheep from Cajamarca and Mantaro, Peru.
(Elsevier Ltd, 2012)
Fascioliasis is a zoonotic parasitic disease caused by Fasciola hepatica and Fasciola gigantica. Of both species, F. hepatica is the only one described in the Americas, mainly transmitted by lymnaeid snail vectors of the ...
Infección por Fasciola hepatica en escolares del distrito de Condebamba, Cajamarca.
(Universidad Nacional Mayor de San Marcos., 2019)
La investigación tuvo como finalidad determinar la prevalencia de Fasciola hepatica
y sus factores de riesgo en escolares de instituciones educativas del nivel primario de
tres caseríos del distrito de Condebamba, ...
Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): A clinical trial and an in vivo efficacy test in sheep
(Elsevier., 2013-07-01)
Fasciolosis caused by Fasciola hepatica, is the most prevalent parasitic disease in dairy cattle from the northern region of Cajamarca, Peru. The control of this parasite is based on the use of Triclabendazole (TCBZ), a ...
A PCR Test Using the Mini-PCR Platform and Simplified Product Detection Methods Is Highly Sensitive and Specific to Detect Fasciola hepatica DNA Mixed in Human Stool, Snail Tissue, and Water DNA Specimens.
(Multidisciplinary Digital Publishing Institute (MDPI)., 2024)
Fasciola hepatica has a complex lifecycle with multiple intermediate and definitive hosts and influenced by environmental factors. The disease causes significant morbidity in children and its prevalent worldwide. There is ...
Efficacy of anthelmintic drugs to control Fasciola hepatica in dairy cattle in Peru.
(Universidad de Antioquia., 2024)
Antecedentes:
Se ha reportado una disminución de la eficacia antiparasitaria del triclabendazol en el control de Fasciola hepatica en vacas lecheras en el valle de Cajamarca, Perú.
Objetivo:
Determinar la eficacia ...
